A AND B COMPGUND RESULTS: SUMMARY

  
 

NAME: C1L, SASE-DALHATIAN, USP
MOREL:
SEAC: SEAC APPROVED (02-93-87) S4OREM;
TESTING STATUS: ACTIVE
DECISION TREE: NA 02-08-85
CHEM AQSTRACTS NUMBER:. GO22-54-8
FENA NUMBERS 3001, 1003
PRE 5.381
SUTAGEN{OITY VEHICLE: OMSO
TP VEHICLE: DIL
GRAL VEHICLE: O14
TV. VEHICLE: INSOLUBLE
SPECIAL ENSTRUCTICNS:
AMES! NEB
UOS!s NEE
Lis: POS#S9: NEG-39
MLPH: PCS+S9° NEG~59
ACRIs IV! NEBATIVE
ACLTOX Ms IP’ LDSO(NE/KG? MALES 433} FEMALES 3021249-347); COMBINED 357
ACUTOX Ris IR) LDSO(MB/KE} MALES 158; FEMALES 119(S9-241} COMBINED 154
RFAATSi:: CRAL MALES J13M5/KG; FEMALES! 175é5/K3i
RAMICES:: ORAL. MALES & FEMALES LBGMG/KG
QELis 1P/0 STUDY ABORTED DUE 10 AN ABSORBANCE /TOXICITY PROBLEM
| ST2: TP/D BALES: S70 LBWa ANA+ AN+ FEMALES: STo: LBWo PNAt AE
HEEL: ORAL S8NG/KO-LOW:NO ERFECT PNALND EFFECT 7ECGND EFFECT GTH:NO EFFECT 44MG?KG-LBNSNOI EZFECT PHAINO EFFECT 7EC3NO EFFECT E
, TRING EFFECT NESATIVE PE4B, NEGATIVE FAG
i: ORAL NO CONCLUSIGN. DUE TO ERROR IN MTB
@t ORAL WEGATIVE, NO SUPPRESSION OF THE PRIMARY’ ANTIBCDY' RESPONSE TO: SRBC,

 

i)
TS

TIS20fTs